Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia
Clinical trial NCT02692742 · COMPLETED
Trial details
- NCT number
- NCT02692742
- Sponsor
- Myelo Therapeutics GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-11-01
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.